造影剤の世界市場：ヨード造影剤、ガドリニウム造影剤、バリウム造影剤、マイクロバブル...市場調査レポートについてご紹介

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 17)
2.1.1 Research Methodology Steps
2.1.2 Secondary and Primary Research Methodology
2.1.2.1 Secondary Research
2.1.3 Key Data From Secondary Sources
2.1.3.1 Primary Research
2.1.3.2 Key Industry Insights
2.1.4 Key Data From Primary Sources
2.1.5 Key Insights From Primary Sources
2.1.6 Market Size Estimation Methodology
2.1.7 Market Forecast Methodology
2.1.8 Market Data Validation and Triangulation
2.1.9 Assumptions

3 Executive Summary (Page No. – 28)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 33)
4.1 Global Contrast Media/ Contrast Agents Market
4.2 Contrast Media/ Contrast Agents Market, By Product and Route of Administration
4.3 Contrast Media/ Contrast Agents Market, By Indication (2015 vs. 2020)

5 Market Overview (Page No. – 37)
5.1 Market Dynamics
5.2 Market Segmentation
5.2.1 Drivers
5.2.1.1 Increase in Demand for Diagnostics & Image Guided Procedures Influences the Sales of Contrast Media
5.2.1.2 Increasing Approvals for Contrast Agents
5.2.1.3 Increase in the Number of Public and Private Diagnostic Centers to Improve Diagnostic Imaging Services
5.2.1.4 Rising Number of Cancer Patients Responsible for Increasing the Number of Diagnostic Procedures
5.2.1.5 Increasing Prevalence of Diseases Associated With the Growth in the Aging Population is Driving the Demand of Various Diagnostic Imaging Modalities
5.2.1.6 Improving Healthcare Infrastructure in Emerging Markets
5.2.2 Restraints
5.2.2.1 Risk Associated With Contrast Agents
5.2.2.2 Need for Highly Skilled Professionals
5.2.3 Opportunities
5.2.3.1 Strong Product Pipeline Likely to Boost the Contrast Media Market
5.2.3.2 Increasing Research on Contrast Agent and Their Applications
5.2.4 Challenge
5.2.4.1 Development of Gamma and Neutron Imaging Solutions

6 Global Contrast Media/ Contrast Agents Market, By Product (Page No. – 52)
6.1 Introduction
6.2 Barium- Based Contrast Media
6.3 Iodinated Contrast Media
6.4 Gadolinium Based Contrast Media
6.5 Microbubbles

7 Global Contrast Media/ Contrast Agents Market, By Medical Procedure (Page No. – 62)
7.1 Introduction
7.2 X-Ray/CT
7.3 MRI
7.4 Ultrasound

8 Global Contrast Media/ Contrast Agents Market, By Route of Administration (Page No. – 70)
8.1 Introduction
8.2 Oral Contrast Media
8.3 Injectable Contrast Media
8.4 Rectal Contrast Media
8.5 Urethral Contrast Media

9 Global Contrast Media/ Contrast Agents Market, By Indication (Page No. – 78)
9.1 Introduction
9.2 Cardiovascular Disorders
9.3 Oncology
9.4 Gastrointestinal Disorders
9.5 Neurological Disorders
9.6 Nephrological Disorders
9.7 Musculoskeletal Disorders

10 Global Contrast Media/ Contrast Agents Market, By Application (Page No. – 87)
10.1 Introduction
10.2 Radiology
10.3 Interventional Radiology
10.4 Interventional Cardiology
10.5 Introduction
10.6 North America
10.6.1 U.S.
10.6.1.1 Increase in the Number of Diagnostic Imaging Centers
10.6.1.2 Increase in the Ageing Population and Rising Prevalence of Chronic Diseases in the U.S.
10.6.1.3 Reimbursement Cuts Under Obama Care
10.6.2 Canada
10.6.2.1 High Incidence Rate of Cancer, Cardiovascular Diseases and Diabetes in Canada
10.6.2.2 Increasing MRI and CT Examinations and Government Funding to Boost the Canadian Market
10.7 Europe
10.7.1 EU5
10.7.1.1 Increase in Investment By Market Players
10.7.1.2 Increasing Incidence and Prevalence of Cancer
10.7.1.3 Healthcare Spending Rises But Remains Weak in EU5 Countries
10.7.1.4 Shortage of Medical Imaging Instruments/Scanners Likely to Hamper the U.K. Market
10.7.2 RoE
10.7.2.1 Increase Focus of Market Players in RoE Countries
10.7.2.2 Increasing Number of MRI and CT Scanners
10.8 Asia-Pacific
10.8.1 Rise in the Ageing Population and Increasing Cancer Incidence
10.8.2 Rising Number of Diagnostic Facilities/Procedures in Japan
10.8.3 Expansion of International Players in China and India
10.8.4 Increasing R&D Investments in China
10.8.5 Favourable Regulatory Changes to Increase the Market in New Zealand and Australia
10.9 Rest of the World
10.9.1 Latin America
10.9.2 The Middle East
10.9.3 Africa

11 Competitive Landscape (Page No. – 136)
11.1 Overview
11.2 Market Share Analysis, Contrast Media/ Contrast Agents Market (2014)
11.2.1 Bayer Healthcare
11.2.2 GE Healthcare
11.3 Competitive Situation and Trends
11.3.1 Market Development (Product Approvals)
11.3.2 Agreements/ Collaborations/ Partnerships/ Strategic Alliances/ Contracts/ Corporate Alliances
11.3.3 Divestments /Investments
11.3.4 Expansions
11.3.5 Others

12 Company Profiles (Page No. – 150)
12.1 GE Healthcare
12.1.1 Business Overview
12.1.2 Financials
12.1.3 Product Portfolio
12.1.4 Recent Developments
12.1.5 MnM View
12.2 Bayer Healthcare
12.2.1 Business Overview
12.2.2 Financials
12.2.3 Product Portfolio
12.2.4 Recent Developments
12.2.5 MnM View
12.3 Bracco Imaging S.P.A. (A Subsidiary of Bracco S.P.A.)
12.3.1 Business Overview
12.3.2 Financials
12.3.3 Product Portfolio
12.3.4 Recent Developments
12.3.5 MnM View
12.4 Guerbet Group
12.4.1 Business Overview
12.4.2 Financials
12.4.3 Product Portfolio
12.4.4 Recent Developments
12.4.5 MnM View
12.5 Mallinckrodt PLC
12.5.1 Business Overview
12.5.2 Financials
12.5.3 Product Portfolio
12.5.4 Recent Developments
12.6 Lantheus Medical Imaging
12.6.1 Business Overview
12.6.2 Financials
12.6.3 Product Portfolio
12.6.4 Recent Developments
12.7 Nanopet Pharma Gmbh
12.7.1 Business Overview
12.7.2 Financials
12.7.3 Product Portfolio
12.7.4 Recent Developments
12.8 CMC Contrast AB
12.8.1 Business Overview
12.8.2 Financials
12.8.3 Product Portfolio
12.8.4 Recent Developments
12.9 Targeson, Inc. Pharma Co., Ltd.
12.9.1 Business Overview
12.9.2 Financials
12.9.3 Product Portfolio
12.9.4 Recent Developments
12.10 Daiichi Sankyo
12.10.1 Business Overview
12.10.2 Financials
12.10.3 Product Portfolio
12.10.4 Recent Developments
12.11 Subhra Pharma Private Limited
12.11.1 Business Overview
12.11.2 Financials
12.11.3 Product Portfolio
12.11.4 Recent Developments

13 Appendix (Page No. – 178)
13.1 Discussion Guide
13.2 Company Developments (2012-2015)
13.2.1 GE Healthcare
13.2.2 Bayer Healthcare
13.2.3 Bracco Imaging S.P.A.
13.3 Guerbet LLC
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports